Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Type 2 Diabetes as the condition and MedlinePlus Genetics as a related topic on the study page. This strengthens the clinical context and provides an additional reference for readers.
    Difference
    0.2%
    Check dated 2025-12-09T18:59:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2025-11-25T10:52:04.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The changes remove a government funding notice banner and a few related-topic links (Type 2 diabetes and MedlinePlus Genetics) from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T06:58:51.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now lists 'Type 2 diabetes' as a condition keyword and adds 'MedlinePlus Genetics' as a related topic; these are minor metadata/content updates that do not alter the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-03T20:58:34.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Type 2 Diabetes Mellitus as the study condition and the related MedlinePlus Genetics topic have been removed from the page.
    Difference
    0.2%
    Check dated 2025-10-27T18:07:05.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added a MedlinePlus Genetics topic: Type 2 diabetes. No deletions present.
    Difference
    0.3%
    Check dated 2025-10-20T13:21:38.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.